← Open Payments lookup

ALYSSA ARREDONDO: Open Payments

NPI 1538370036 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$659 in 30 payments from 10 companies in 2025. Trend: 2023 $707 · 2024 $596 · 2025 $659

Food & beverage: $659
CompanyPaymentsAmount
ARS Pharmaceuticals Operations, Inc.11$168
Optinose US, Inc.2$162
GlaxoSmithKline, LLC.4$85
GENZYME CORPORATION4$65
SANOFI-AVENTIS U.S. LLC3$51
Organon LLC2$36
AstraZeneca Pharmaceuticals LP1$27
Genentech USA, Inc.1$26
Novartis Pharmaceuticals Corporation1$21
ALK-Abello, Inc1$17

Products named: NEFFY, Xhance, DUPIXENT, NUCALA, TRELEGY ELLIPTA, Xolair, Rhapsido, Grastek.

Industry payments across TX — which companies pay providers there.